|
 Other bidders for the Belgian consumer healthcare company include
Perrigo Co and private German drugmaker Boehringer Ingelheim GmBH,
the sources told Bloomberg.
Final bid offers are due beginning November, Bloomberg reported,
citing the people, who added that the deal could fetch Omega more
than 4 billion euros ($5.1 billion).
Actavis was not immediately available for comment.
Omega Pharma sells prescription-free medicines, healthcare products
and over-the-counter items such as wart treatments and sun tan
lotions.
(Reporting by Amrutha Penumudi in Bangalore; Editing by Maju Samuel)
[© 2014 Thomson Reuters. All rights
reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
[to top of second column] |
